| (Values in U.S. Thousands) | Dec, 2024 | Dec, 2023 | Dec, 2015 | Dec, 2014 | Dec, 2013 |
| Sales | 0 | 0 | 2,170 | 1,540 | 2,670 |
| Sales Growth | unch | -100.00% | +40.91% | -42.32% | +16.59% |
| Net Income | -71,110 | -63,850 | -37,230 | -46,420 | -33,220 |
| Net Income Growth | -11.37% | -71.50% | +19.80% | -39.74% | +15.58% |
Bioage Labs Inc (BIOA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
BioAge Labs Inc. is a clinical-stage biopharmaceutical company. It involved in developing therapeutic product candidates for metabolic diseases, such as obesity, by targeting the biology of aging. BioAge Labs Inc. is based in RICHMOND, Calif.
Fiscal Year End Date: 12/31